Workflow
X @Bloomberg
Bloombergยท2025-10-10 15:40

Novo cut its cell therapy division, which has been trying to find a cure for type 1 diabetes, as the Ozempic maker continues to slash headcount to focus on lucrative areas of obesity and diabetes treatment https://t.co/T6F7l62GAA ...